When was EBR Systems founded?

EBR Systems was founded in 2003 and raised its 1st funding round 2 years after it was founded.

Where is EBR Systems located?

EBR Systems is headquartered in Sunnyvale, United States. It is registered at Jelgava, Kārklu iela 4 - 86.

How many employees does EBR Systems have?

As of Sep 30, 2026, the latest employee count at EBR Systems is 154.

Is EBR Systems a funded company?

EBR Systems is a funded company, having raised a total of $180M across 7 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Dec 22, 2005.

When was the latest funding round of EBR Systems?

EBR Systems' latest funding was a $***** Series F round on Oct 04, 2019, with participation from 5 investors.

Where does EBR Systems rank among its competitors?

EBR Systems ranks 2nd amongst 71 active competitors, of which 23 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was AtaCor Medical, which secured $75M in Oct, 2025.

Who are the top competitors of EBR Systems?

EBR Systems' top competitors include AtaCor Medical, AtriCure and CardioFocus. Among them, AtaCor Medical secured the most recent funding round in October, 2025.

EBR Systems - 2026 Company Profile, Funding, Competitors & Financials

EBR Systems is a public company based in Sunnyvale (United States), founded in 2003. It operates as a Revolutionizing cardiac rhythm management with leadless pacing technology for heart failure. EBR Systems has raised $180M in funding from investors like M.H. Carnegie & Co, Brandon Capital and Delphi Ventures. The company has 71 active competitors, including 23 funded and 21 that have exited. Its top competitors include companies like AtaCor Medical, AtriCure and CardioFocus.

Company Details

Revolutionizing cardiac rhythm management with leadless pacing technology for heart failure. This company is dedicated to transforming the lives of patients suffering from heart failure. They develop technology that enables physicians to deliver optimal cardiac pacing. They focus on blending clinical insights with technological ingenuity to overcome the limitations of conventional cardiac resynchronization therapy (CRT). Their WiSE technology introduces a leadless, versatile, and physiologic approach to pacing the heart. They prioritize innovation, patient needs, and team growth. They are committed to advancing cardiac rhythm management through groundbreaking medical devices. They offer a breakthrough product, a team-oriented culture, and opportunities for career growth. They are a medical device company focused on cardiac care, offering a pioneering system set to redefine cardiac care.

Website: www.ebrsystemsinc.com/
Registered Address: Jelgava, Kārklu iela 4 - 86

Key Metrics

Founded Year

2003

Location

Sunnyvale, United States

Stage

Public

Total Funding

$180M in 7 rounds

Latest Funding Round

Series F, Oct 04, 2019, $*****

Investors

M.H. Carnegie & Co & 13 more

Ranked

2^nd among 71 active competitors

Employee Count

154 as on Sep 30, 2026

Similar Companies

AtaCor Medical & 90 more

Exit Details

Public

View EBR Systems' full profile

EBR Systems is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
EBR CIN: 43603036467 , Latvia, Active	Jun 12, 2008	€0 - €1M (As on Dec 31, 2024)	3 (As on Dec 31, 2022)	-
EBR SYSTEMS, INC. CIN: 654147127 , Australia, Active	Sep 30, 2021	-	-
Ebr Systems, Inc. CIN: 57-1164669 , United States, Active		-	-	-

EBR Systems got listed on Nov 24, 2021.

Click here to take a look at EBR Systems's IPO in detail

EBR Systems has raised a total funding of $180M over 7 rounds. Its first funding round was on Dec 22, 2005. Its latest funding round was a Series F round on Oct 04, 2019 for $*****. 5 investors participated in its latest round. EBR Systems has 13 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of EBR Systems:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 04, 2019	5342390	Series F	8607093	4534388	5010979	2792044
Nov 14, 2017	4925767	Series F	8758248	3493215	7799567	Split Rock Partners & 2 more
Jul 15, 2014	3736554	Series E	5367978	1419110	Emergent Medical Partners	Split Rock Partners & 3 more

Access funding benchmarks and valuations. Sign up today!

View details of EBR Systems's funding rounds and investors

EBR Systems' employee count trend

EBR Systems has 154 employees as of Sep 26. Here is EBR Systems's employee count trend over the years:

Uncover EBR Systems' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of EBR Systems include AtaCor Medical, AtriCure and CardioFocus. Here is the list of Top 10 competitors of EBR Systems, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AtaCor Medical 2014, San Clemente (United States), Series D	Transforming cardiac rhythm management with innovative extravascular pacing and defibrillation solutions	$137M	aMoon, Broadview Ventures & 7 others	64/100
2nd	EBR Systems 2003, Sunnyvale (United States), Public	Revolutionizing cardiac rhythm management with leadless pacing technology for heart failure	$180M	Horizon 3 Healthcare, Ascension Ventures ... & 12 others	62/100
3rd	AtriCure 2000, Mason (United States), Public	Medical device company focused on atrial fibrillation and pain management	-	Stage Capital, Camden Partners & 2 others	59/100
4th	CardioFocus 1990, Marlborough (United States), Series E	Endoscopically guided catheter for ablation	$261M	H.I.G. Capital, KBL & 22 others	58/100
5th	CathVision 2013, Copenhagen (Denmark), Series B	Provider and developer of an AI-based cardiac ablation therapy software and device	$36.1M	Vaekstfonden, Borean Innovation & 6 others	57/100
6th	Kestra Medical Technologies 2014, Kirkland (United States), Public	Device to protect and support patients at risk of cardiovascular disorders	$196M	Bain Capital Life Sciences, Longitude Capital ... & 9 others	54/100
7th	TyRx 1998, Monmouth Junction (United States), Acquired	Antibacterial envelopes for cardiac implants	$70.8M	MemorialCare Innovation Fund, HLM Venture Partners ... & 6 others	47/100
8th	Cameron Health 2001, San Clemente (United States), Acqui-Hired	Subcutaneous Implantable Defibrillator	$158M	Alloy Ventures, Western Technology Investment ... & 14 others	45/100
9th	nContact Surgical 2005, Morrisville (United States), Acquired	Cardiac ablation technology	$53.2M	Finistere Ventures, Harbert Management & 5 others	45/100
10th	Append Medical 2016, Or Yehuda (Israel), Series A	Developer of a device for the left atrial appendage closure system	$11.8M	ALIVE, Shoni Health Ventures & 3 others	45/100